AbbVie Plans $10 Billion Bond Sale to Finance Apogee Therapeutics Acquisition
AbbVie launches a $10 billion bond offering to finance the Apogee Therapeutics deal, marking a major pharmaceutical M&A debt issuance in 2026.
AbbVie launches a $10 billion bond offering to finance the Apogee Therapeutics deal, marking a major pharmaceutical M&A debt issuance in 2026.
BofA’s Mark Cabana warns Treasury bonds face renewed selling pressure if the Federal Reserve fails to clarify its rate path, highlighting the…
Bank of Korea minutes reveal majority support for additional rate hikes to tackle inflation and growth, reinforcing the central bank's tightening cycle.
U.S. Treasuries advanced, pushing yields lower, as falling crude oil prices dampened inflation expectations and trimmed market-implied odds of further Federal Reserve…
Fed’s Paulson remarks on open-minded rate stance ease taper fears, buoy bonds and risk assets while weakening the dollar.
Treasury Secretary Bessent's yen intervention is portrayed as a makeshift measure to temporarily stabilize bond markets, underscoring the fragile link between currency…
Global bond funds pivot to European sovereign debt as tariff concerns and Fed rate uncertainty drive a risk-off move, boosting demand for…
Non-resident Indian inflows into bonds and loans are compressing yields and boosting bank stocks, driven by rupee stability and government tax breaks.
A Laos power firm issued a deep-junk dollar bond at 11.125% in a rare frontier-market high-yield offering, signaling steep borrowing costs and…
Record issuance of catastrophe bonds in 2026, fueled by escalating wildfire threats, marks a milestone in the shift of natural-disaster risk from…
US Treasuries rallied after oil prices fell and Treasury Secretary Bessent pledged yen support, driving 10-year yields lower as inflation fears abated…
Chile peso bonds face selloff as prolonged Strait of Hormuz closure threatens to drive up oil import costs, stoke inflation, and widen…